Ceftazidime pentahydrate 2,000 mg, avibactam Na 500 mg
Indications/Uses
In combination w/ metronidazole for complicated intra-abdominal infection (cIAI). Complicated UTI including pyelonephritis (cUTI); hospital-acquired pneumonia (HAP) including ventilator-associated pneumonia (VAP).
cIAI 1 vial over 120 min every 8 hr over 2 hr for 5-14 days. cUTI including pyelonephritis 1 vial over 120 min every 8 hr over 2 hr for 5-10 days, may be increased up to 14 days in patient w/ bacteremia. HAP including VAP 1 vial over 120 min every 8 hr over 2 hr for 7-14 days. Renal impairment CrCl 31-50 mL/min 1,000 mg/250 mg every 8 hr over 2 hr, 16-30 mL/min 750 mg/187.5 mg every 12 hr over 2 hr, 6-15 mL/min 750 mg/187.5 mg every 24 hr over 2 hr, ESRD including on haemodialysis 750 mg/187.5 mg every 48 hr over 2 hr.
Hypersensitivity to ceftazidime pentahydrate, avibactam Na or any cephalosporins. Severe hypersensitivity (eg, anaphylactic reaction) to any other β-lactams eg, penicillins, monobactams or carbapenems.
J01DD52 - ceftazidime and beta-lactamase inhibitor ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Manage Account
Change Password
Sign Out
